Go to Site Home Page Go to University of Pittsburgh Home Page Go to UPMC Home Page

Luminex Core Facility

Hillman Cancer Center, Lab 1.18
5117 Centre Avenue
Pittsburgh, PA 15213
412-623-7748 (phone)
412-623-1415 (fax)

The University of Pittsburgh Cancer Institute (UPCI) Luminex Core Facility was founded in 2003 by Dr. Anna Lokshin and is located in the Hillman Cancer Center.  With over 22 years of combined Luminex assay experience, the UPCI Luminex Core Facility staff is familiar with many Luminex protocols and offers researchers accurate, reliable, and reproducible processing and analysis services.
Luminex technology is a flexible platform that permits the simultaneous quantitative analysis of up to 100 different proteins, peptides, DNA molecules and much more from as little as 50μl of sample in a single microtiter well.  Luminex is compatible with various sample matrices such as serum, cell culture supernatants, plasma, saliva, spinal fluid, tissue homogenate supernatants, urine, and ascites.  Popular applications for Luminex technology include protein, gene and transcription factor expression profiling, isotyping, mRNA expression, microRNA expression, and signal transduction; new applications are added frequently.
The UPCI Luminex Core Facility can process and analyze samples using commercially available manufactured kits or unique Core-developed kits.  The UPCI Luminex Core Facility can also develop custom analyte Luminex assays using investigator-supplied antibodies and a protein standard. 
For additional information on the services provided and pricing, please contact 412-623-7748 or visit our website at http://www.upci.upmc.edu/cbf/luminex.cfm.